ZepboundSan Francisco, CA

Zepbound in San Francisco, CA

For San Francisco, California residents, geographic distance from mainland pharmacies has historically affected access to specialty medications. Zepbound® is the FDA-approved Injectable pen Tirzepatide product manufactured by Eli Lilly; Pacific-region retail pricing varies by pharmacy. Weight Method offers a separate telehealth program: licensed California providers evaluate eligible patients and prescribe compounded Tirzepatide, dispensed by a U.S.-licensed 503A pharmacy. Compounded Tirzepatide is not FDA-approved. The Weight Method program is priced at $329/month uniformly, shipped directly to your San Francisco address.

FDA-approved Zepbound prescribed by licensed providers. Delivered to your door.

Take the Free Quiz

Free consultation · No commitment · Results in weeks

Patient
Patient
Patient
Patient
Patient
4.9/5

From 2,000+ patients · San Francisco is already seeing results

Licensed Providers
FDA-Approved Medications
Free Shipping
HIPAA Compliant
Updated May 2026Medically reviewed by licensed providers

Zepbound in San Francisco, CA: an FDA-approved GLP-1 medication shown to achieve 15-22% body weight loss in clinical trials. Weight Method offers Zepbound to patients in San Francisco from $329/month with virtual consultations and direct-to-door shipping.

How does this medication work for weight loss?

Zepbound® by Eli Lilly is the FDA-approved Injectable pen Tirzepatide product, taken Once weekly and approved in 2023 for Chronic weight management. Tirzepatide works by mimicking incretin hormones that regulate hunger and satiety, reducing appetite and helping you feel full with smaller portions. Weight Method is a separate telehealth program for San Francisco residents: licensed providers evaluate eligible patients and prescribe compounded Tirzepatide, dispensed by a U.S.-licensed 503A pharmacy. Compounded Tirzepatide is not FDA-approved. The Weight Method program starts at $329/month and includes the provider evaluation, the medication, ongoing care, and home delivery.

What treatment options are available locally?

Finding a provider in San Francisco who combines GLP-1 expertise with genuine bilingual capability can be difficult. Weight Method bridges that gap: our providers prescribe compounded Tirzepatide (dispensed by a U.S.-licensed 503A pharmacy; compounded Tirzepatide is not FDA-approved) with cultural sensitivity, our support team speaks your language, and our pricing at $329/month is transparent regardless of insurance status.

Ready to Get Started?

Answer a few quick questions to see if you qualify.

Check Eligibility

Your Treatment Options

Compounded GLP-1 medications dispensed by U.S.-licensed 503A pharmacies.

Starting at$199/mo
Semaglutide
Most PopularIn Stock

Semaglutide

Compounded semaglutide. Once-weekly subcutaneous injection.

  • Weekly injection
  • Gradual dose increase
  • Provider monitoring
  • Free shipping
Check Eligibility
Tirzepatide
In Stock

Tirzepatide

Compounded tirzepatide. Dual-action GLP-1/GIP, once-weekly subcutaneous injection.

  • Weekly injection
  • Dual hormone action
  • Provider monitoring
  • Free shipping
Check Eligibility

Frequently Asked Questions

Weight Method is a telehealth program. You take an online health assessment, a licensed California provider reviews your history and meets with you virtually, and — if appropriate — they prescribe compounded Tirzepatide, which is dispensed by a U.S.-licensed 503A compounding pharmacy and shipped to your San Francisco address. The $329/month price covers the medication, the virtual provider consultations, dosing management, and free delivery — there are no hidden fees. Compounded Tirzepatide is not FDA-approved.

Most patients complete their online assessment and virtual consultation within 24–48 hours. If your Weight Method provider determines that compounded Tirzepatide is appropriate for you, your prescription is typically shipped within 2–3 business days and arrives at your San Francisco, CA address shortly after. The entire process from assessment to medication in hand usually takes less than a week. Compounded Tirzepatide is dispensed by a U.S.-licensed 503A pharmacy and is not FDA-approved.

The most common side effects of Tirzepatide are gastrointestinal — mild nausea, decreased appetite, and occasional digestive discomfort. These typically occur during the first few weeks or after dose increases and diminish as your body adjusts. Your Weight Method provider follows a gradual dose-escalation protocol designed to reduce side effects and will monitor your progress throughout treatment. Discuss your full medical history with your provider before starting any GLP-1 therapy.

No. Weight Method operates on a direct-pay model with transparent pricing. The compounded Tirzepatide program starts at $329/month and covers your medication, provider consultations, and free delivery to San Francisco. No insurance claims, no prior authorizations, and no surprise bills. Compounded Tirzepatide is dispensed by a U.S.-licensed 503A pharmacy and is not FDA-approved.

Zepbound® is a Injectable pen manufactured by Eli Lilly, FDA-approved since 2023 for Chronic weight management. It contains Tirzepatide, which mimics natural incretin hormones to reduce appetite, slow gastric emptying, and help your body regulate hunger. Zepbound® is taken Once weekly. Weight Method does not sell Zepbound®; we are a separate program that prescribes compounded Tirzepatide (dispensed by a U.S.-licensed 503A pharmacy and not FDA-approved) starting at $329/month.

Start Your Treatment

Consult with a licensed provider in California and start Zepbound from $329/month.

Get Started Now

Free consultation. No commitment.

Other Brands in San Francisco

Ozempic in San FranciscoWegovy in San FranciscoMounjaro in San FranciscoRybelsus in San FranciscoTirzepatide in San Francisco

Nearby Cities

Zepbound in Daly City, CAZepbound in South San Francisco, CAZepbound in Emeryville, CAZepbound in Alameda, CA

See More

All About ZepboundTirzepatide in San FranciscoClinics in San Francisco